Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Takeda Pharmaceutical Co Ltd Management Call Transcript

Jan 10, 2022 / 11:00PM GMT
Release Date Price: $14.24 (+2.37%)
Operator

Before starting, I'd like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in the most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of the presentation.

Now please let me introduce today's presenters and panel: Christophe Weber, President and CEO; Andrew Plump, President of R&D; Costa Saroukos, Chief Financial Officer; and Ramona Sequeira, President, U.S. Business Unit and Global Portfolio Commercialization.

First, Christophe will give you a presentation. And after that, we will have a question-and-answer session. Now we would like to begin.

Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director

Thank you very much. It's a great pleasure to be with you. I wish we could be setting the meeting rooms

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot